Epic Sciences Appoints Michael Rodriguez as Chief Financial Officer

Strong Financial and Operational Leader Complements Innovative, Fast Growth Team

Jan 21, 2014, 08:00 ET from Epic Sciences

SAN DIEGO, Jan. 21, 2014 /PRNewswire/ -- Epic Sciences announced today the appointment of Michael Rodriguez as chief financial officer. Mr. Rodriguez has more than 20 years of experience as a strategic financial and operational executive guiding creative and innovative companies. Prior to joining Epic Sciences, Mr. Rodriguez served as chief operating officer of Clarient Diagnostic Services, a GE Healthcare molecular diagnostics and laboratory services business. 

"Michael has an impressive track record as a cross-functional executive leader to create and serve fast growth, complex and high energy companies," said Murali Prahalad, Ph.D., president and CEO of Epic Sciences. "Not only does he have strong financial and operational acumen in both private and public companies, he also has proven success in executing strategic initiatives, driving productive change and cultivating high-performance teams to increase results and profits."

"Joining Epic Sciences gives me a chance to align my passion to fight cancer with an amazing team who has the focus and drive to bring important new cancer management tools to doctors and patients," said Michael Rodriguez, chief financial officer of Epic Sciences. "Epic's mission to develop a simple blood test that can accurately detect circulating tumor cells to monitor and manage cancer treatments represents a significant advancement for oncology diagnostics."

As chief operating officer of Clarient Diagnostic Services, Mr. Rodriguez led an organization of more than 350 people in lab operations, information technology, quality assurance, project and portfolio management, facilities, materials management and environmental health and safety. Prior to his promotion to COO, he served as CFO, building a best-in-class organization and guiding Clarient to profitable operations during his first year of tenure, facilitating its $587 million sale to GE Healthcare. Prior to Clarient, Mr. Rodriguez served as senior vice president and chief financial officer of Endocare, executive vice president and chief financial officer of Directfit, and senior financial capacities for Tickets.com, and EDiX Corporation. He received an MBA from Stanford University and a B.S. in accounting from the University of Southern California.

About Epic Sciences

Epic Sciences, Inc. is a privately held company that is developing new diagnostics to improve and personalize the treatment and management of cancer. Epic was founded on a powerful platform to identify and characterize rare cells, including circulating tumor cells (CTCs). Epic has partnered with leading pharmaceutical companies, major cancer centers, the National Cancer Institute (NCI), to advance this technology to improve clinical oncology and cancer therapeutic development.

For more information, please visit http://www.epicsciences.com or follow on Twitter @epicsciences.  To learn more about Epic's partnering program and clinical trial services, please email cdx@epicsciences.com

SOURCE Epic Sciences